Throughout his career, Willy Kruh has worked directly with executive leadership of numerous multinational corporations, having notably stewarded KPMG International in his capacity as the organization's Global Chair of Consumer & Retail to its highest growth rates in 2016, 2017 and 2018, taking it from a $2.5B business to over $4B when he retired at the end of 2019.Willy's multifaceted technical expertise spans the professional services spectrum, wholly relevant (and beneficial) to the dynamism and diverse portfolio of PlantEXT, a company on the cutting edge of both therapeutic treatments and preventatives through pharmaceutical cannabis, applicable to a wide variety of pervasive diseases and their symptoms.As PlantEXT Chief Executive Officer, Willy Kruh works alongside the founder of the parent company, Israel Plant Sciences Limited, leveraging his strategic market entry and data and analytics expertise and moreover, his passion behind brokering new and challenging opportunities. Willy will lead and assist PlantEXT throughout its continued growth as an organization, finding effective, lasting treatment solutions for inflammation related medical conditions and beyond.
Listed skills include Restructuring, Ipo, Strategic Planning, Business Strategy, and 30 others.